Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-25

Clinical Trial Update: Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial [Phase 4]

View source ↗

Summary

Phase 4 trial comparing CrossBoss first strategy to standard wire escalation for crossing coronary chronic total occlusions; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: North Texas Veterans Healthcare System | Conditions: Arteriosclerosis, Coronary Artery Disease | Phase 4 | Status: COMPLETED